Evidence map›Paper›PMID 26114287›Full record

ArticlePLoS neglected tropical diseases2015

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.

Gemma Louise Kay, Andrew Millard, Martin J Sergeant, Nicholas Midzi, Reggis Gwisai, Takafira Mduluza, Alasdair Ivens, Norman Nausch, Francisca Mutapi, Mark Pallen

Erratum issuedAbstract readComparative Study
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 68 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Research square · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Parasitosis byMicroorganisms · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gemma Louise KayMicrobiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom.
Andrew MillardMicrobiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom.
Martin J SergeantMicrobiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom.
Nicholas MidziNational Institute of Health Research, Causeway, Harare, Zimbabwe.
Reggis GwisaiMurewa District Hospital, Murewa, Zimbabwe.
Takafira MduluzaDepartment of Biochemistry, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe.
Alasdair IvensInsitute of Immunology and Infection Research, Centre for Immunology, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.
Norman NauschInsitute of Immunology and Infection Research, Centre for Immunology, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.
Francisca MutapiInsitute of Immunology and Infection Research, Centre for Immunology, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.
Mark PallenMicrobiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom.

Funding

Wellcome Trust 095831Wellcome Trust WT082028MA
6 · The paper itself

Abstract

backgroundSeveral infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children.

methodsStool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test.

resultsPre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline.

conclusionsThere are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.

Indexed as

AnimalsChildDysbiosisFecesHigh-Throughput Nucleotide SequencingHumansMicrobiotaMultivariate AnalysisPhylogenyPraziquantelRNA, Ribosomal, 16SSchistosomiasis haematobiaPraziquantelRNA, Ribosomal, 16S

Identifiers

PMID26114287
PMCPMC4482744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.